CHANGES IN THE MAMMARY GLANDS DURING MENOPAUSE AND THEIR ASSOCIATION WITH METABOLIC SYNDROME
Keywords:
Keywords: menopause, mammary gland, metabolic syndrome, insulin resistance, obesity, breast tissue remodeling, inflammation, estrogen deficiencyAbstract
Menopause is accompanied by profound endocrine, metabolic, and structural alterations that affect multiple organs and tissues, including the mammary glands. Declining ovarian function and estrogen deficiency contribute not only to breast tissue remodeling but also to the development of metabolic syndrome, a condition characterized by visceral obesity, insulin resistance, dyslipidemia, and chronic low-grade inflammation. Growing evidence suggests that these metabolic abnormalities significantly influence breast morphology and may increase the risk of both benign and malignant breast diseases.
This narrative review analyzes current scientific evidence regarding morphological and functional changes occurring in the mammary glands during menopause and explores their relationship with metabolic syndrome. Particular attention is paid to hormonal deficiency, adipose tissue redistribution, insulin resistance, inflammatory pathways, and alterations in breast tissue composition. The interaction between menopausal endocrine changes and metabolic disturbances is examined as a critical mechanism underlying breast remodeling and disease susceptibility.
Available data indicate that metabolic syndrome may accelerate age-related breast tissue alterations and contribute to an increased incidence of mastopathy, mammographic density changes, and breast cancer risk. Early identification and correction of metabolic abnormalities may therefore play an important role in preserving breast health during menopause.
References
1.Alberti, K.G.M.M. et al. (2009). Harmonizing the metabolic syndrome. Circulation, 120(16), 1640–1645.
2.Boyd, N.F., Martin, L.J., Yaffe, M.J. & Minkin, S. (2011). Mammographic density and breast cancer risk. Breast Cancer Research, 13(6), 223.
3.Cummings, S.R., Tice, J.A., Bauer, S. et al. (2009). Prevention of breast cancer in postmenopausal women. New England Journal of Medicine, 361(4), 340–351.
4.Key, T.J., Appleby, P.N. & Reeves, G.K. (2013). Body mass index, serum sex hormones, and breast cancer risk. Journal of the National Cancer Institute, 95(16), 1218–1226.
5.Lovejoy, J.C., Champagne, C.M., de Jonge, L. et al. (2008). Increased visceral fat and decreased energy expenditure during menopause. The Journal of Clinical Endocrinology & Metabolism, 93(11), 4232–4238.
6.Picon-Ruiz, M., Morata-Tarifa, C., Valle-Goffin, J.J. et al. (2017). Obesity and adverse breast cancer risk. Cancer Metastasis Reviews, 36(2), 285–301.
7.Rose, D.P. & Vona-Davis, L. (2014). Biochemical and molecular mechanisms linking obesity and breast cancer. Endocrine-Related Cancer, 21(3), R365–R384.
8.Santen, R.J., Yue, W., Wang, J.P. & Fan, P. (2020). Estrogen metabolism and breast cancer. Journal of Steroid Biochemistry and Molecular Biology, 204, 105754.
9.Simpson, E.R. (2003). Sources of estrogen and their importance. The Journal of Steroid Biochemistry and Molecular Biology, 86(3–5), 225–230.
10.Wildman, R.P. et al. (2012). Lipid changes during the menopausal transition. Journal of Clinical Lipidology, 6(6), 631–639.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal